昭栄薬品 has upwardly revised its earnings forecast for the six months ended September. The article does not state the specific extent of the revision or the figures in the revised forecast.
昭栄薬品 has upwardly revised its earnings forecast for the six months ended September.
The article provides no new figures or specific details about the period and reports only the fact of the upward revision.